To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.
Summary
What This Bill Does
The bill exempts fentanyl-related substances Section 202(c) of the Controlled Substances Act (21 U.S.C, requires removal from schedule I(e) of fentanyl-related substances Section 201 of the Controlled Substances Act (21 U.S.C, and requires clarification of certain registration requirements related to research Section 302(c)(1) of the Controlled Substances Act (21 U.S.C. It relies on compliance mandates, definition changes, exemptions, and delegation of rulemaking. The main policy areas are Environmental Groups, Science & Space, Healthcare, and Environment.
Who Benefits and How
Public beneficiaries or protected communities affected by the clause could face reduced risk, Researchers and scientific institutions affected by the bill could face lower compliance burdens, and Patients and health care consumers affected by the bill could face lower compliance burdens.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Researchers and scientific institutions affected by the bill would take on compliance duties, and Patients and health care consumers affected by the bill would take on compliance duties.
Key Provisions
- Exempts fentanyl-related substances Section 202(c) of the Controlled Substances Act (21 U.S.C.
- Requires removal from schedule I(e) of fentanyl-related substances Section 201 of the Controlled Substances Act (21 U.S.C.
- Requires clarification of certain registration requirements related to research Section 302(c)(1) of the Controlled Substances Act (21 U.S.C.
- Provides review of research registration process.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill exempts fentanyl-related substances Section 202(c) of the Controlled Substances Act (21 U.S.C, requires removal from schedule I(e) of fentanyl-related substances Section 201 of the Controlled Substances Act (21 U.S.C, and requires clarification of certain registration requirements related to research Section 302(c)(1) of the Controlled Substances Act (21 U.S.C.
Key Policy Areas
Environmental Groups, Science & Space, Healthcare, Environment
Primary Purpose
The bill exempts fentanyl-related substances Section 202(c) of the Controlled Substances Act (21 U.S.C, requires removal from schedule I(e) of fentanyl-related substances Section 201 of the Controlled Substances Act (21 U.S.C, and requires clarification of certain registration requirements related to research Section 302(c)(1) of the Controlled Substances Act (21 U.S.C.
Policy Domains
Whole bill
Identified Gains
- Public beneficiaries or protected communities affected by the clause
- Researchers and scientific institutions affected by the bill
- Patients and health care consumers affected by the bill
- Oil and gas producers, refiners, or users affected by the bill
- Environmental and public health interests affected by the bill
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Researchers and scientific institutions affected by the bill
- Patients and health care consumers affected by the bill
- Public beneficiaries or protected communities affected by the clause
Sponsors
Legislative Progress
IntroducedMr. Luetkemeyer (for himself, Mrs. Hinson, Mr. Bacon, Mr. DesJarlais, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology